Close
ACHEMA MIDDLE EAST 2026

Cell And Gene Therapy Boost With Novel UK Biotech Centres

The National Health Service Blood and Transplant from the UK, which takes care of blood as well as platelet donations as well as organ,...

US President Looks To Double The Drugs For Price Negotiation

President Joe Biden is looking to double the number of medicines that Medicare can help negotiate rates for and thereby enable the government to...

Monash University In Australia Leads $15M Mitochondrial Clinical Trial Drive

Almost 50 children in Australia are born every year with a devastating mitochondrial disease that has an expected lifespan of just 5 years. In...

Rapid Cutback of Intracranial Pressure By Injectable Peptide

It has come to light that patient with idiopathic intracranial hypertension- IIH can be treated with an injectable peptide used for type 2 diabetes....

Tumors Can Get Destroyed By Bacteria-Aid To Immune System

The introduction of bacteria to a tumor’s microenvironment goes on to create the possibility of acute inflammation, which further triggers the immune system’s primary...

Default Eligibility Results In Better Clinical Trial Nods

A new approach that has been created at the Medical University of South Carolina that specifically aims at enhancing clinical trial eligibility has shown...

Researchers Develop Revolutionary Treatment In Bone Cancer

Researchers from the University of East Anglia- UEA have come up with a new non-invasive treatment for bone cancer that happens to be effective...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...